Eli Lilly warns that two insulin products will be in short supply
Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products.
Mar 25, 2024
0
1
Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products.
Mar 25, 2024
0
1
Although there are many differences between type 1 diabetes and type 2 diabetes, there are also similarities, such as inflammation of the insulin-producing cells. Researchers at Lund University have studied a protein called ...
Mar 21, 2024
0
10
Researchers from the German Diabetes Center (DDZ) and the Robert Koch Institute have discovered a law for the relationship between mortality and age in people with diabetes: According to this law, mortality in people with ...
Mar 21, 2024
0
8
Tobacco exposure before birth and beginning smoking during childhood/adolescence were significantly associated with the development of type 2 diabetes in adulthood, especially for people with a high genetic risk of type 2 ...
Mar 20, 2024
0
6
More recent medications for Type 2 diabetes and weight loss shown to have positive effects on cardiovascular and kidney health were not always prescribed or accessible to people who could benefit from them.
Mar 20, 2024
0
30
A small, long-term study of almost 500 children in Massachusetts has found that regularly drinking sugary drinks and 100% fruit juices during childhood and adolescence may be linked to a higher risk of developing Type 2 diabetes ...
Mar 19, 2024
0
1
Diabetes is a widespread metabolic disorder affecting over 500 million adults worldwide. The most common form is type-2 diabetes (T2D), characterized by peripheral insulin resistance.
Mar 19, 2024
0
13
A new study led by researchers at McLean Hospital (a member of Mass General Brigham) and Washington State University used advances in digital testing to demonstrate that naturally occurring glucose fluctuations impact cognitive ...
Mar 18, 2024
0
59
A landmark study by the German Diabetes Center (DDZ), published in The Lancet Diabetes & Endocrinology, sheds new light on the heterogeneity of type 2 diabetes. The researchers have employed an innovative algorithm to stratify ...
Mar 18, 2024
0
27
Researchers from Germans Trias i Pujol Research Institute (IGTP) and Ahead Therapeutics SL have been exploring a treatment based on liposome-type nanoparticles to address the autoimmunity of type 1 diabetes for years. A study ...
Mar 18, 2024
0
2